Omega Healthcare Investors, Inc. (NYSE:OHI) Stock Holdings Decreased by Victory Capital Management Inc.

Victory Capital Management Inc. trimmed its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 4.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 50,032 shares of the real estate investment trust’s stock after selling 2,114 shares during the period. Victory Capital Management Inc.’s holdings in Omega Healthcare Investors were worth $2,036,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. CreativeOne Wealth LLC raised its stake in Omega Healthcare Investors by 44.4% during the 1st quarter. CreativeOne Wealth LLC now owns 9,662 shares of the real estate investment trust’s stock valued at $306,000 after acquiring an additional 2,969 shares in the last quarter. Epoch Investment Partners Inc. purchased a new position in Omega Healthcare Investors during the 1st quarter worth approximately $206,000. Lazard Asset Management LLC increased its holdings in shares of Omega Healthcare Investors by 259.1% in the 1st quarter. Lazard Asset Management LLC now owns 4,043 shares of the real estate investment trust’s stock valued at $128,000 after purchasing an additional 2,917 shares during the period. Price T Rowe Associates Inc. MD increased its stake in shares of Omega Healthcare Investors by 2.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 133,166 shares of the real estate investment trust’s stock worth $4,218,000 after acquiring an additional 3,466 shares during the last quarter. Finally, Silvercrest Asset Management Group LLC raised its position in Omega Healthcare Investors by 0.7% during the first quarter. Silvercrest Asset Management Group LLC now owns 935,193 shares of the real estate investment trust’s stock valued at $29,618,000 after acquiring an additional 6,050 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on OHI shares. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a research report on Thursday, October 31st. BMO Capital Markets upped their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday, October 7th. Royal Bank of Canada lifted their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday, November 11th. Berenberg Bank started coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 target price on the stock. Finally, Truist Financial raised their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research note on Wednesday, September 4th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors has a consensus rating of “Hold” and a consensus target price of $40.00.

Omega Healthcare Investors Price Performance

OHI stock opened at $40.11 on Monday. The company has a market capitalization of $10.83 billion, a P/E ratio of 29.49, a PEG ratio of 1.25 and a beta of 0.99. The company has a fifty day moving average price of $40.62 and a 200-day moving average price of $37.01. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a $0.67 dividend. The ex-dividend date was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.68%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.

Insider Activity

In related news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.